Cargando…
Mechanism of Inhibition of the GluA1 AMPA Receptor Channel Opening by the 2,3-Benzodiazepine Compound GYKI 52466 and a N-Methyl-Carbamoyl Derivative
[Image: see text] 2,3-Benzodiazepine derivatives, also known as GYKI compounds, represent a group of the most promising synthetic inhibitors of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors. Here we investigate the mechanism of inhibition of the GluA1 channel opening and the...
Autores principales: | Wu, Andrew, Wang, Congzhou, Niu, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025570/ https://www.ncbi.nlm.nih.gov/pubmed/24738995 http://dx.doi.org/10.1021/bi5002079 |
Ejemplares similares
-
Pharmacological Preconditioning with GYKI 52466: A Prophylactic Approach to Neuroprotection
por: Goulton, Chelsea S., et al.
Publicado: (2010) -
Small-angle neutron scattering studies on the AMPA receptor GluA2 in the resting, AMPA-bound and GYKI-53655-bound states
por: Larsen, Andreas Haahr, et al.
Publicado: (2018) -
Stargazin and γ4 slow the channel opening and closing rates of GluA4 AMPA receptors
por: Pierce, Vincen D., et al.
Publicado: (2019) -
Activity-Dependent Ubiquitination of GluA1 and GluA2 Regulates AMPA Receptor Intracellular Sorting and Degradation
por: Widagdo, Jocelyn, et al.
Publicado: (2015) -
Postsynaptic VAMP/Synaptobrevin Facilitates Differential Vesicle Trafficking of GluA1 and GluA2 AMPA Receptor Subunits
por: Hussain, Suleman, et al.
Publicado: (2015)